| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.7 |